Five-year outcomes and cardiac remodeling following left atrial appendage occlusion

B Liu, J Luo, M Gong, Z Li, B Shi, X Zhang… - … Interventions in Aging, 2021 - Taylor & Francis
Purpose LAAO has been an alternative therapy to oral anticoagulants (OACs) for stroke
prophylaxis in patients with nonvalvular atrial fibrillation (NVAF) with elevated CHA2DS2 …

[HTML][HTML] Long term outcomes after left atrial appendage closure with the LARIAT device—Stroke risk reduction over five years follow-up

R Litwinowicz, M Bartus, M Burysz, M Brzeziński… - PLoS …, 2018 - journals.plos.org
Introduction Left atrial appendage closure (LAAC) with LARIAT offers an alternative to oral
anticoagulation (OAC) for patients with atrial fibrillation. The aim of this study was to present …

[PDF][PDF] Left atrial appendage closure: patient, device and post-procedure drug selection

A Tzikas, MW Bergmann - EuroIntervention, 2016 - researchgate.net
Left atrial appendage closure (LAAC), a device-based therapy for stroke prevention in
patients with atrial fibrillation, is considered an alternative to oral anticoagulation therapy …

2015 ACC/HRS/SCAI left atrial appendage occlusion device societal overview

FA Masoudi, H Calkins, CJ Kavinsky, JP Drozda… - Journal of the American …, 2015 - jacc.org
Left atrial appendage (LAA) occlusion devices have the potential to influence the clinical
approach to stroke prevention in patients with atrial fibrillation (AF). A number of …

Percutaneous left atrial appendage closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS registry

P Mazzone, G D'Angelo, D Regazzoli, G Molon… - Journal of Interventional …, 2018 - Springer
Purpose The WATCHMAN device for Left Atrial Appendage Occlusion (LAAO) has proven to
be an effective alternative to oral anticoagulation (OAC) in patients with atrial fibrillation (AF) …

Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation

S Gloekler, S Shakir, J Doblies, AA Khattab… - Clinical Research in …, 2015 - Springer
Background Transcatheter left atrial appendage (LAA) occlusion has been proven to be an
effective treatment for stroke prophylaxis in patients with atrial fibrillation. For this purpose …

Comparison in Patients< 75 Years of Age-Versus-Those> 75 Years on One-year-Events With Atrial Fibrillation and Left Atrial Appendage Occluder (From the …

AE Nasasra, J Brachmann, T Lewalter… - The American Journal …, 2020 - europepmc.org
Left atrial appendage closure (LAAC) is an alternative to oral anticoagulation therapy in
patients with non-valvular atrial fibrillation for the prevention of embolic stroke and systemic …

Left atrial appendage occlusion: rationale, evidence, devices, and patient selection

JP Piccini, H Sievert, MR Patel - European heart journal, 2017 - academic.oup.com
Atrial fibrillation (AF) is a worldwide epidemic associated with significant morbidity and
mortality, often due to disabling or fatal thromboembolic stroke. Oral anticoagulation is highly …

Day‐case percutaneous left atrial appendage occlusion—Safety and efficacy

T Williams, O Alsanjari, J Parker… - Catheterization and …, 2018 - Wiley Online Library
Objectives We evaluated the safety and efficacy of percutaneous left atrial appendage (LAA)
occlusion performed as a day case procedure. Background LAA occlusion has been shown …

The Watchman FLX–a new device for left atrial appendage occlusion–design, potential benefits and first clinical experience

M Grygier, A Olasińska-Wiśniewska… - … Cardiology/Postępy w …, 2017 - termedia.pl
Although convincing data showed that left atrial appendage (LAA) occlusion could be used
as an alternative to oral anticoagulants, LAA occlusion has emerged as a common …